Sunshine Biopharma Inc.
SBFM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001402328
No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $32.6K in total; no superinvestor holds it.
Other share classesSBFMW
13F holders, Q3 2024
Institutional positions in Sunshine Biopharma Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 10
- −1 vs. Q2 2024
- Shares held
- 35.0K
- −181.6K (−83.8%) vs. Q2 2024
- Total value
- $111.3K
- +$21.7K (+24.2%) vs. Q2 2024
- New holders
- 7
- 1 more added
- Sold out
- 8
- 2 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SBFM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 9 | $32.6K |
| Q1 2026 | 12 | $127.1K |
| Q4 2025 | 13 | $141.7K |
| Q3 2025 | 14 | $337.3K |
| Q2 2025 | 12 | $187.2K |
| Q1 2025 | 11 | $151.7K |
| Q4 2024 | 12 | $61.8K |
| Q3 2024 | 10 | $111.3K |
| Q2 2024 | 11 | $89.6K |
| Q1 2024 | 15 | $346.2K |
| Q4 2023 | 15 | $745.7K |
| Q3 2023 | 11 | $415.1K |
| Q2 2023 | 10 | $1.25M |
| Q1 2023 | 13 | $292.4K |
| Q4 2022 | 12 | $261.8K |
| Q3 2022 | 12 | $341.1K |
| Q2 2022 | 18 | $802.1K |
| Q1 2022 | 13 | $3.55M |
| Q4 2021 | 1 | $17.0K |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Sunshine Biopharma Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 34,480 | $109.6K | 0.00% | +34,380+34,380.0% | Added |
| Nordwand Advisors, LLC | 500 | $1.59K | 0.00% | +500 | New |
| National Bank of Canada | 7 | $22 | 0.00% | −58−89.2% | Reduced |
| Morgan Stanley | 1 | $3 | 0.00% | −999−99.9% | Reduced |
| Jaffetilchin Investment Partners, LLC | 1 | $3 | 0.00% | +1 | New |
| Advisor Group Holdings, Inc. | 1 | $3 | 0.00% | +1 | New |
| Rise Advisors, LLC | 1 | $3 | 0.00% | +1 | New |
| Farther Finance Advisors, LLC | 1 | $3 | 0.00% | +1 | New |
| TD Waterhouse Canada Inc. | 1 | $3 | 0.00% | +1 | New |
| Federation des caisses Desjardins du Quebec | 1 | $3 | 0.00% | +1 | New |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −76,967−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −44,008−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −45,022−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −27,856−100.0% | Sold out |
| Sabby Management, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −1,529−100.0% | Sold out |
| Main Street Group, LTD | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1−100.0% | Sold out |